Abstract:Objective To explore the practical results of “de-channel” transport diagnosis and treatment mode in the treatment of acute ischemic cerebral infarction. Methods A retrospective cohort study was used. The patients with acute ischemic cerebral infarction admitted to Nanchong Central Hospital were selected, 145 patients from December 2018 to November 2019 were divided into control group, and 188 patients from March 2020 to December 2021 were divided into study group. Among them, the study group adopted the “de-channel” transport diagnosis and treatment mode for treatment, while the control group adopted the standard process for treatment. The optimization effect of the first aid process of the two groups of patients was compared, and the thrombolytic efficiency of all patients, the NIHSS score before and after thrombolysis, the length of hospitalization and the good prognosis rate of 90-day follow-up were recorded. Results The door-to-needle time (DNT), blood sampling, blood examination, family decision-making time, the initial evaluation time from the patient to the emergency doctor, the reception time of the professional stroke doctor, the time of CT and laboratory examination report, and the time of medication in the study group were significantly shorter than those in the control group (P＜0.05). NIHSS score after thrombolysis of the study group was lower than that of the control group, and the effective rate of thrombolysis was higher than that of the control group (90.72% vs 82.07%, P＜0.05). The hospital stay of the study group was significantly shorter than that of the control group, and the good prognosis rate of the 90-day follow-up was higher than that of the control group (42.55% vs 28.97%, P＜0.05). Conclusion The “de-channel” transport diagnosis and treatment mode can shorten the time from the treatment of acute stroke patients to the completion of treatment, improve the timeliness of thrombolytic therapy, thereby improving the thrombolytic efficiency of patients and improving the prognosis.